Japanese TCM Fungus Discovery Leads To Novartis MS Drug
This article was originally published in PharmAsia News
Executive Summary
Japanese researchers have brought fingolimod, the basis for a traditional Chinese medicine, to the edge of U.S. FDA approval as a multiple sclerosis drug